Results 61 to 70 of about 58,815 (317)

HYSTYOCYTOSIS X: VERIFICATION OF DIAGNOSIS

open access: yesVestnik Dermatologii i Venerologii, 2018
A clinical case of histiocytosis X, rarely found in the practice of a dermatovenereologist, is described, the pathognomonic clinical symptoms of this dermatosis, including skin lesions, that occur in 50 to 80 % of cases of all forms are displayed.
V. V. Starostenko   +3 more
doaj   +1 more source

Growth of children with Langerhans cell histiocytosis [PDF]

open access: yes, 1995
Conclusion: GH deficiency is not a common manifestation of LCH in childhood and GH provocation tests are only indicated when there is a poor or decelerating growth rate.
Egeler, R.M. (Maarten)   +3 more
core   +1 more source

Histiocytosis X: Langerhans’ Cell Histiocytosis

open access: yesHematology/Oncology Clinics of North America, 1987
Histiocytosis X is a complex and poorly understood entity. Nevertheless, it would appear as if certain themes are found recurrently throughout the literature dealing with this disease and a review of them serves as a useful summary. 1. Problems with Nomenclature.
openaire   +2 more sources

Choroidal Neovascular Membrane Formation and Retinochoroidopathy in a Patient with Systemic Langerhans Cell Histiocytosis: A Case Report and Review of the Literature [PDF]

open access: yes, 2012
We report a case of bilateral atrophic retinochoroidopathy with choroidal neovascular membrane (CNVM) formation in a patient with systemic Langerhans cell histiocytosis (LCH).
Foster, Charles Stephen   +3 more
core   +2 more sources

Long‐term outcomes of stereotactic radiofrequency ablation in hypothalamic hamartomas: A single‐center experience

open access: yesEpilepsia, EarlyView.
Abstract Objective Hypothalamic hamartomas (HHs) lead to refractory epilepsy, and minimally invasive surgical approaches are standard of care for affected patients. Stereotactic radiofrequency thermocoagulation (SRT) is one of the treatment methods recognized to achieve seizure freedom. This study reports surgical outcome from a single center reporting
Peter Christoph Reinacher   +9 more
wiley   +1 more source

Splenic sea-blue (ceroid) histiocytosis due to hypertriglyceridemia: Report of a case and review of literature

open access: yesHuman Pathology: Case Reports, 2017
Sea-blue histiocytosis is a rare condition that can be often identified in bone marrow, spleen, liver as well as other organs. It can be frequently detected in bone marrow of patients with myeloproliferative neoplasms as well as non-neoplastic conditions
Kacy A. Krehbiel   +3 more
doaj   +1 more source

Bilateral breast Rosai‐Dorfman disease screen detected by mammography

open access: yesClinical Case Reports, 2023
Rosai‐Dorfman disease (RDD) is a proliferative disorder of histiocytes typically found in nodal sites and commonly observed in females. Patients often present with systemic symptoms such as fever, lymphadenopathy, and weight loss.
Christina Sumner   +6 more
doaj   +1 more source

Diagnosis of Rosai-Dorfman Disease by Fine Needle Aspiration Cytology in a Case with Cervical Lymphadenopathy and Nasal Mass [PDF]

open access: yes, 2011
We report a case of Rosai-Dorfman Disease, a rare non neoplastic proliferative disorder of the cells of macrophage-histiocyte family, in a case with cervical lymphadenopathy and nasal mass diagnosed by fine needle aspiration ...
Jena, M
core   +1 more source

WHO classification of skin tumours: key updates in the fifth edition

open access: yesHistopathology, EarlyView.
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy   +29 more
wiley   +1 more source

GPNMB immunohistochemistry is a useful ancillary tool for the diagnosis of pulmonary lymphangioleiomyomatosis

open access: yesHistopathology, EarlyView.
We evaluated the diagnostic utility of GPNMB immunohistochemistry in LAM. GPNMB showed strong expression in LAM cells, while the differential diagnostic mimics showed no or only low expression. Based on its 100% sensitivity and specificity in our cohort, GPNMB is a highly reliable immunohistochemical marker for the diagnosis of LAM.
Fatime Szalai   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy